FDA Warning Letter — ImprimisRx NJ LLC
The FDA took a Warning Letter action against ImprimisRx NJ LLC on May 26, 2023 (Ledgewood, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- ImprimisRx NJ LLC
- Date
- May 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Ledgewood, NJ (United States)